Back to companies
Metagenomi Therapeutics, Inc.
MGXUSNASDAQPharmaceuticals & HealthcareMetagenomi Therapeutics, Inc.
Revenue
$25.2mn
YoY -51.8%
Operating income
-$96.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API